WebNov 5, 2024 · The INCB 57643-103 trial is designed to further evaluate the safety and tolerability of INCB057643 monotherapy in patients with relapsed or refractory MF. Methods: INCB 57643-103 (NCT04279847) is a phase 1, single-arm, open-label, two-part dose confirmation and expansion study evaluating INCB057643 in patients with measurable … WebOther names: INCB81776, INCB 81776 , INCB081776. Contact us to learn more about our Premium Content: News alerts, weekly reports and conference planners. Associations (0) …
incb081776 - My Cancer Genome
WebINCB81776-101. A Phase 1a/1b Study exploring the safety and tolerability of INCB081776 +/- retifanlimab in participants with advanced malignancies Protocol: INCB 81776-101 EudraCT Number: 2024-004867-26 Een Fase 1a/1b, open label... Web英文名称 :AXL receptor tyrosine kinase 中文名称 :AXL受体酪氨酸激酶 靶点别称 :EC:2.7.10.1,EC 2.7.10,UFO,AXL Transforming Sequence/Gene,AXL Oncogene,EC 2.7.10.1,JTK11,Tyro7,ARK,Tyrosine-protein kinase receptor UFO,AXL,AXL Receptor Tyrosine Kinase 上市药物数量 :2 临床药物数量 :23 最高研发阶段 :批准上市 … bkpf-19r44ac
Kræftens Bekæmpelse - Find forsøgsbehandling - INCB 81776-101
WebJun 12, 2024 · Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H1 2024 is a market research report available at US $3500 for a Single User PDF License from RnR Market Research Reports Library. WebSEARCH TIPS. A California contractor license number doesn't contain alphabetic characters. Each contractor's plastic pocket license will show the respective license number. WebMar 22, 2024 · The International Narcotics Control Board (INCB) is the independent and quasi-judicial monitoring body for the implementation of the United Nations international … bkp face reveal